Source: FinanzNachrichten

Hua Medicine: Hua Medicine Announces 2024 Annual Results

SHANGHAI, Mar 28, 2025 - (ACN Newswire) - - HuaTangNing completed its first full year for reimbursement under the National Reimbursement Drug List (NRDL), with continued expansion in hospital cover...

Read full article »
Hua Medicine's Competitors | Hua Medicine's News | Hua Medicine's Financials
Stay up-to-date with the latest news on Hua Medicine
Annual Revenue
$100K-5.0M
Employees
100-250
Li Chen's photo - President & CEO of Hua Medicine

President & CEO

Li Chen

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Hua Medicine